Dr. Meg Mooney helps coordinate cancer clinical trial networks across the country and internationally, and also organizes initiatives related to innovative cancer treatment reviews and precision medicine. In this episode, Mooney discusses a new natural history study the National Cancer Institute launched for cancer patients with COVID-19, as well as the work being done in drug discovery and development during this time.
HealthCast
Season 1
Episode 10
18m listen
Dr. Meg Mooney, Associate Director of CTEP, NCI
Share
The office coordinates nationwide testing of new treatment approaches for cancer.
-
Meg Mooney Associate Director of CTEP NCI
Related Content
-
NEA Leverages AI to Drive Software Development
NEA CIO Jim Tunnessen discusses AI-assisted software development, modernization, cybersecurity and responsible AI adoption across government.
7m watch -
VA OIG CIO Outlines AI Deployment, Modernization Priorities
As the VA's internal watchdog, the OIG is using AI to improve oversight while monitoring how emerging technologies are adopted across the agency.
11m listen -
Agile Acquisition Becomes DISA's New Battlefield Advantage
DODNet leaders say 90-day OTA cycles and flexible engineering models are helping DISA deliver capabilities at the speed of cyber threats.
17m watch -
USPIS Uses AI to Advance Criminal Investigations
The U.S. Postal Inspection Service is using AI to uncover crime patterns, support investigations and improve workforce efficiency.
5m watch
